Amyloid β oligomers constrict human capillaries in Alzheimer's disease via signaling to pericytes

Science. 2019 Jul 19;365(6450):eaav9518. doi: 10.1126/science.aav9518. Epub 2019 Jun 20.

Abstract

Cerebral blood flow is reduced early in the onset of Alzheimer's disease (AD). Because most of the vascular resistance within the brain is in capillaries, this could reflect dysfunction of contractile pericytes on capillary walls. We used live and rapidly fixed biopsied human tissue to establish disease relevance, and rodent experiments to define mechanism. We found that in humans with cognitive decline, amyloid β (Aβ) constricts brain capillaries at pericyte locations. This was caused by Aβ generating reactive oxygen species, which evoked the release of endothelin-1 (ET) that activated pericyte ETA receptors. Capillary, but not arteriole, constriction also occurred in vivo in a mouse model of AD. Thus, inhibiting the capillary constriction caused by Aβ could potentially reduce energy lack and neurodegeneration in AD.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease / metabolism
  • Alzheimer Disease / physiopathology*
  • Amyloid beta-Peptides / chemistry
  • Amyloid beta-Peptides / metabolism*
  • Animals
  • Biopsy
  • Capillaries / physiopathology*
  • Cerebral Cortex / blood supply*
  • Cerebral Cortex / pathology
  • Cerebrovascular Circulation*
  • Constriction, Pathologic / physiopathology*
  • Endothelin-1 / metabolism
  • Humans
  • Hypoxia / metabolism
  • Hypoxia / physiopathology
  • Mice
  • Pericytes / metabolism*
  • Protein Multimerization
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species / metabolism
  • Receptor, Endothelin A / metabolism
  • Signal Transduction
  • Vascular Resistance

Substances

  • Amyloid beta-Peptides
  • Endothelin-1
  • Reactive Oxygen Species
  • Receptor, Endothelin A